There is evidence that decreased levels of the C1 inhibitor are associated with sepsis [41] (but not in neonatal sepsis [42]), acute myocardial infarction [43], lymphoma [44,45], and lymphoproliferative disorders [46]. This evidence concerns the gene SERPING1 and acute myocardial infarction.